Document is current
Any future updates will be listed below
-
Authors
Pulido-Saavedra, Alejandra https://orcid.org/0009-0005-7948-2050
Oliva, Henrique Nunes Pereira https://orcid.org/0000-0001-6452-9833
Prudente, Tiago Paiva https://orcid.org/0000-0002-8803-5384
Kitaneh, Razi https://orcid.org/0000-0001-9791-1115
Nunes, Eric J. https://orcid.org/0009-0003-7802-8740
Fogg, Colleen https://orcid.org/0009-0003-2084-1798
Funaro, Melissa C. https://orcid.org/0000-0001-6846-4846
Weleff, Jeremy https://orcid.org/0000-0001-8071-7412
Nia, Anahita Bassir https://orcid.org/0000-0002-3890-3518
Angarita, Gustavo A. https://orcid.org/0000-0001-5568-9878
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (R21 DA046030, P30 DA046345)
National Institute of Mental Health (1R13MH132238)
- License Information
-
More Information
Article History
Received: 10 June 2024
Revised: 1 November 2024
Accepted: 19 November 2024
First Online: 21 January 2025
Declarations
:
: Not applicable.
: All authors reviewed manuscript and provided consent for publication.
: Dr. Bassir Nia is a member of the Scientific Advisory Board of Synendos Therapeutics AG, Switzerland.
